Behavioral Safety and Fentanyl Education: BSAFE
San Francisco Department of Public Health · with University of California, San Francisco · NCT07219082
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 160
- US sites recruiting
- 1
- Study start
- August 11, 2026
- Record last updated
- August 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
BSAFE is a randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among people who use stimulants who may have unintentional fentanyl use (UFU). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the efficacy of BSAFE vs attention-control.
Being studied: BSAFE Intervention; Attention control
Conditions: Drug Overdose; Drug Overdose Accidental
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Aged 18 years or older,
- Reports intentional cocaine or methamphetamine use ≥7 of past 30 days,
- Urine positive for cocaine or methamphetamine and negative for opioids/fentanyl prior to enrollment
- Be able to provide the names of at least 2 persons who can consistently locate their whereabouts.
- Reports at least one suspected unintentional fentanyl use event, including unexpected sedation or unexpected fentanyl-positive bodily fluid drug testing result.
Exclusion Criteria
- Reports past 30-day intentional use of any opioid or ongoing use of an opioid antagonist (e.g., naltrexone)
- Intends to leave area in coming year,
- Unable to communicate in English or Spanish,
- Any other condition that, in the PI's judgment, interferes with safe study participation or adherence to study procedures.
Recruiting US locations
San Francisco Department of Public Health
San Francisco, CA 94102
Site contact: Phillip Coffin, MD · 628-217-6282 · phillip.coffin@sfdph.org
Study contacts (from the official record)
- Phillip O Coffin, MD, MIA · (628) 217-6282 · phillip.coffin@sfdph.org
- Xochitl Luna Marti, MPH · (628) 217-6235 · xochitl.lunamarti@sfdph.org
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55